Green Fresh Biotech expects H1 net loss at RMB 1 million-RMB 4 million

PUBT · 1d ago
Green Fresh Biotech expects H1 net loss at RMB 1 million-RMB 4 million
  • Green Fresh forecast a net loss attributable to owners of RMB 1-4 million for the six months ended June 30, 2026.
  • That compares with a net loss of RMB 12.07 million in the prior-year period.
  • Performance improvement tied to higher carrageenan sales volumes driven by competitive pricing, lifting revenue and gross profit.
  • Net operating cash inflow improved more than sevenfold versus the six months ended June 30, 2025.
  • Interim results are being finalized, with publication expected before end-August 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Green Fresh Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260812-12281683), on August 12, 2026, and is solely responsible for the information contained therein.